Interferon Lambda Satellite Meeting Abstract Submission

Satellite Meeting for the Scientific Community Working in the Field of Type III IFNs (IFN-λ)

The IFN-λ will be held as a satellite meeting of Cytokines 2022, on Saturday 24 and Sunday 25 September 2022 at the Hilton Waikoloa Village. The purpose of the meeting is to promote research on IFN-λs by enhancing interdisciplinary communication and encouraging new collaborations. 

The abstract submission for the Interferon Lambda Satellite meeting is completely separate and unrelated to the abstract submission for Cytokines 2022 and ILC4 Joint meeting. You can submit the same abstract to the main joint meeting (under the appropriate topics for the joint meeting that best fits your abstract) in addition to the Interferon Lambda Satellite Meeting as this meeting occurs immediately following the joint meeting.

By end-June, the submitter will be informed whether the abstract has been accepted for the Satellite Meeting. The notification will be sent to this email address. Please ensure that the notification can reach you by adapting your spam filter accordingly and by putting our address on your white list.

Accepted abstracts will be available on the Interferon Lambda Satellite meeting website two weeks prior to the event and will be available on the meeting's virtual platform (which will be separate from the Joint meeting virtual platform).

Participants to the IFN-λ meeting must be registered to the Cytokines 2022 and will be requested to pay an additional fee to attend the satellite meeting. 

Abstract Submission Topics:

  • IFN-λ biology
  • IFN-λ therapy
  • genetic association of variants in the IFN-λ region with multiple phenotypes
  • response to treatment
  • the role of IFN-λ in hepatitis C virus (HCV) and other infections
  • hepatic fibrosis
  • cancer

Participants to the IFN-λ meeting must be registered to the Cytokines 2022 and will be requested to pay an additional fee to attend the satellite meeting and must be registered to present.

Name, Institution, City and Country of Presenting/Corresponding Author. *
Email Address of Corresponding/Presenting Author *
Submit the TITLE of your abstract in ALL CAPS. For example: INTERFERON-LAMBDA PROTECTION IN A MURINE MODEL OF SARS-COV-2 INFECTION How you choose to enter your information is how it will appear to the public if your abstract is selected. Do NOT include the authors, institutions or contact information in the TITLE of the abstract and ONLY the ABSTRACT TITLE should be in ALL CAPS. *
List all the authors here, as well as their Institutions, City and Country, in the order they should appear in the abstract. Please include the presenting/corresponding author's name as the first author. *
(Maximum characters: 2000)
You have characters left.
The body of your abstract should be typed or pasted here. It should NOT INCLUDE your ABSTRACT TITLE or the authors, affiliations and contact information which will be included in the Authors section. It must not exceed 2000 characters to comply with the online form. You will be advised of your word count usage throughout the submission process as you save and move to the next step. You will be able to include a longer version of the abstract in the final step which is a Word Document upload of your full abstract. *
(Maximum characters: 2000)
You have characters left.
Please choose the topic from the list that best describe your abstract. *
Upload a fully formatted abstract, including the Title, Authors, Body of the Abstract (no character limits) and references, disclosures and any tables or images you wish to include. The file must be a Word document (not pdfs) and will be included in the abstract book, exactly as submitted, if accepted for presentation. *

Fields marked with * are required.

Your form submission WILL be encrypted using SSL to ensure your privacy.

Engage With Us

International Cytokine & Interferon Society, Copyright 2022 | Privacy Policy